Market Capitalization of Fredun Pharmaceuticals (FREDUN)
As of July 24, 2026, Fredun Pharmaceuticals (FREDUN) market capitalisation is ₹1515.88 Cr ($168.43M), with 1.69 Cr shares outstanding at a current price of ₹895.20 on BSE, ranking 1312 out of 5363 companies by market cap in our screener. Fredun Pharmaceuticals operates in the Healthcare sector and is classified as a Small Cap stock. For live price, earnings and the complete company profile, see Fredun Pharmaceuticals screener.
Market Cap History of Fredun Pharmaceuticals (Last 10 Years)
FREDUN market capitalisation from year-end BSE closing prices over the last 10 years. Compare with FREDUN fundamental valuation to assess whether the stock is under or overvalued.
End of Year Market Cap History — Fredun Pharmaceuticals
FREDUN year-end market cap in INR and USD with closing share price and annual change — BSE closing prices. View FREDUN annual price range for the annual high/low range and current price position.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹1515.88 Cr
$168.43M USD
|
₹895.20 | BSE | -43.28% |
| 2025 |
₹2672.60 Cr
$296.96M USD
|
₹1578.30 | BSE | +114.08% |
| 2024 |
₹1248.42 Cr
$138.71M USD
|
₹737.25 | BSE | -15.14% |
| 2023 |
₹1471.09 Cr
$163.45M USD
|
₹868.75 | BSE | -22.45% |
| 2022 |
₹1896.88 Cr
$210.76M USD
|
₹1120.20 | BSE | +32.45% |
| 2021 |
₹1432.14 Cr
$159.13M USD
|
₹845.75 | BSE | +95.21% |
| 2020 |
₹733.64 Cr
$81.52M USD
|
₹433.25 | BSE | +92.30% |
| 2019 |
₹381.51 Cr
$42.39M USD
|
₹225.30 | BSE | -33.17% |
| 2018 |
₹570.83 Cr
$63.43M USD
|
₹337.10 | BSE | +223.20% |
| 2017 |
₹176.62 Cr
$19.62M USD
|
₹104.30 | BSE | +125.51% |
| 2016 |
₹78.32 Cr
$8.70M USD
|
₹46.25 | BSE | - |